{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:59:13Z","timestamp":1773410353112,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["MRC, 2017R1A5A2015541"],"award-info":[{"award-number":["MRC, 2017R1A5A2015541"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["MRC, 2017R1A5A2015541"],"award-info":[{"award-number":["MRC, 2017R1A5A2015541"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["MRC2017R, A5A2015541"],"award-info":[{"award-number":["MRC2017R, A5A2015541"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["MRC, 2017R1A5A2015541"],"award-info":[{"award-number":["MRC, 2017R1A5A2015541"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["MRC2017R, A5A2015541"],"award-info":[{"award-number":["MRC2017R, A5A2015541"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is closely related to neuroinflammation, and the increase in inflammatory cytokine generation and inducible nitric oxide synthase (iNOS) expression in the brain of a patient with AD is well known. Excessive cytokines can stimulate iNOS in microglia and astroglia and overproduce nitric oxide, which can be toxic to neurons. The disease\u2013gene\u2013drug network analysis based on the GWAS\/OMIM\/DEG records showed that miconazole (MCZ) affected AD through interactions with NOS. Inhibiting iNOS can reduce neuroinflammation, thus preventing AD progression. To investigate the prophylactic role of antifungal agent in the AD development, a lipopolysaccharide-induced memory disorder mouse model was used, and cognitive function was assessed by Morris water maze test and passive avoidance test. MCZ treatment significantly attenuated cognitive impairment, suppressed iNOS and cyclooxygenase-2 expression, and activation of astrocyte and microglial BV2 cells, as well as reduced cytokine levels in the brains and lipopolysaccharide-treated astrocytes and microglia BV2 cells. In further mechanism studies, Pull-down assay and iNOS luciferase activity data showed that MCZ binds to iNOS and inhibited transcriptional activity. Our results suggest that MCZ is useful for ameliorating the neuroinflammation-mediated AD progression by blocking iNOS expression.<\/jats:p>","DOI":"10.1038\/s41419-020-2619-5","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T12:22:04Z","timestamp":1597407724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Antifungal drug miconazole ameliorated memory deficits in a mouse model of LPS-induced memory loss through targeting iNOS"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6799-667X","authenticated-orcid":false,"given":"In Jun","family":"Yeo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaesuk","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Ju","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6656-6523","authenticated-orcid":false,"given":"Sang-Bae","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6534-9575","authenticated-orcid":false,"given":"Jin Tae","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"2619_CR1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","volume":"13","author":"AS Association","year":"2017","unstructured":"Association, A. S. 2017 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 13, 325\u2013373 (2017).","journal-title":"Alzheimer\u2019s Dement."},{"key":"2619_CR2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0022-510X(91)90251-2","volume":"106","author":"P Ince","year":"1991","unstructured":"Ince, P., Irving, D., MacArthur, F. & Perry, R. H. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson\u2019s disease and non-demented elderly control patients. J. Neurological Sci. 106, 142\u2013152 (1991).","journal-title":"J. Neurological Sci."},{"key":"2619_CR3","first-page":"CD012197","volume":"5","author":"MT Ruthirakuhan","year":"2018","unstructured":"Ruthirakuhan, M. T., Herrmann, N., Abraham, E. H., Chan, S. & Lanctot, K. L. Pharmacological interventions for apathy in Alzheimer\u2019s disease. Cochrane Database Syst. Rev. 5, CD012197 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2619_CR4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fneur.2018.00108","volume":"9","author":"SF Cappa","year":"2018","unstructured":"Cappa, S. F. The quest for an Alzheimer therapy. Front. Neurol. 9, 108 (2018).","journal-title":"Front. Neurol."},{"key":"2619_CR5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"2619_CR6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1042\/BST0351119","volume":"35","author":"GC Brown","year":"2007","unstructured":"Brown, G. C. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem. Soc. Trans. 35, 1119\u20131121 (2007).","journal-title":"Biochem. Soc. Trans."},{"key":"2619_CR7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JAD-2008-15405","volume":"15","author":"CA Colton","year":"2008","unstructured":"Colton, C. A. et al. The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP. J. Alzheimer\u2019s Dis.: JAD 15, 571\u2013587 (2008).","journal-title":"J. Alzheimer\u2019s Dis.: JAD"},{"key":"2619_CR8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1006\/bbrc.1994.2716","volume":"205","author":"M-A Dorheim","year":"1994","unstructured":"Dorheim, M.-A., Tracey, W. R., Pollock, J. S. & Grammas, P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer\u2032 s disease. Biochem. Biophys. Res. Commun. 205, 659\u2013665 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2619_CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3940(02)00095-2","volume":"322","author":"J Haas","year":"2002","unstructured":"Haas, J., Storch-Hagenlocher, B., Biessmann, A. & Wildemann, B. Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer\u2019s dementia and following stimulation with \u03b2-amyloid 1\u201342 in vitro. Neurosci. Lett. 322, 121\u2013125 (2002).","journal-title":"Neurosci. Lett."},{"key":"2619_CR10","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1523\/JNEUROSCI.5047-06.2007","volume":"27","author":"R Medeiros","year":"2007","unstructured":"Medeiros, R. et al. Connecting TNF-\u03b1 signaling pathways to iNOS expression in a mouse model of Alzheimer\u2019s disease: relevance for the behavioral and synaptic deficits induced by amyloid \u03b2 protein. J. Neurosci. 27, 5394\u20135404 (2007).","journal-title":"J. Neurosci."},{"key":"2619_CR11","doi-asserted-by":"crossref","first-page":"12867","DOI":"10.1073\/pnas.0601075103","volume":"103","author":"C Colton","year":"2006","unstructured":"Colton, C. et al. NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 103, 12867\u201312872 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2619_CR12","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-2-20","volume":"2","author":"P Mander","year":"2005","unstructured":"Mander, P. & Brown, G. C. Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration. J. Neuroinflammation. 2, 20 (2005).","journal-title":"J. Neuroinflammation."},{"key":"2619_CR13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1098-1136(199603)16:3<276::AID-GLIA10>3.0.CO;2-X","volume":"16","author":"CC Chao","year":"1996","unstructured":"Chao, C. C. et al. Cytokine\u2010stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 16, 276\u2013284 (1996).","journal-title":"Glia"},{"key":"2619_CR14","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1248\/bpb.30.2345","volume":"30","author":"J-B Kim","year":"2007","unstructured":"Kim, J.-B. et al. Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-\u03baB inactivation in RAW 264.7 macrophage cells. Biol. Pharm. Bull. 30, 2345\u20132351 (2007).","journal-title":"Biol. Pharm. Bull."},{"key":"2619_CR15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00702-004-0188-x","volume":"112","author":"G Stuchbury","year":"2005","unstructured":"Stuchbury, G. & M\u00fcnch, G. Alzheimer\u2019s associated inflammation, potential drug targets and future therapies. J. Neural Transm. 112, 429\u2013453 (2005).","journal-title":"J. Neural Transm."},{"key":"2619_CR16","doi-asserted-by":"crossref","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","volume":"45","author":"G Koscielny","year":"2017","unstructured":"Koscielny, G. et al. Open Targets: a platform for therapeutic target identification and validation. Nucleic Acids Res. 45, D985\u2013D994 (2017).","journal-title":"Nucleic Acids Res."},{"key":"2619_CR17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","volume":"11","author":"FC Odds","year":"2003","unstructured":"Odds, F. C., Brown, A. J. & Gow, N. A. Antifungal agents: mechanisms of action. Trends Microbiol. 11, 272\u2013279 (2003).","journal-title":"Trends Microbiol."},{"key":"2619_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1439-0507.1997.tb00200.x","volume":"40","author":"K Vermuyten","year":"1997","unstructured":"Vermuyten, K., Laurijssens, L. & Vanden Bossche, H. Azole antifungals: weak inhibitors of inducible nitric oxide synthase in mouse and human cells. Mycoses 40, 119\u2013125 (1997).","journal-title":"Mycoses"},{"key":"2619_CR19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1074\/jbc.274.2.930","volume":"274","author":"N Sennequier","year":"1999","unstructured":"Sennequier, N., Wolan, D. & Stuehr, D. J. Antifungal imidazoles block assembly of inducible NO synthase into an active dimer. J. Biol. Chem. 274, 930\u2013938 (1999).","journal-title":"J. Biol. Chem."},{"key":"2619_CR20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.expneurol.2016.11.012","volume":"288","author":"AM Nicaise","year":"2017","unstructured":"Nicaise, A. M. et al. iPS-derived neural progenitor cells from PPMS patients reveal defect in myelin injury response. Exp. Neurol. 288, 114\u2013121 (2017).","journal-title":"Exp. Neurol."},{"key":"2619_CR21","first-page":"337","volume":"10","author":"R Yang","year":"2017","unstructured":"Yang, R. et al. Miconazole protects blood vessels from MMP9-dependent rupture and hemorrhage. Dis. Model Mech. 10, 337\u2013348 (2017).","journal-title":"Dis. Model Mech."},{"key":"2619_CR22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature14335","volume":"522","author":"FJ Najm","year":"2015","unstructured":"Najm, F. J. et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature 522, 216 (2015).","journal-title":"Nature"},{"key":"2619_CR23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.niox.2005.04.005","volume":"12","author":"RL Davis","year":"2005","unstructured":"Davis, R. L., Sanchez, A. C., Lindley, D. J., Williams, S. C. & Syapin, P. J. Effects of mechanistically distinct NF-\u03baB inhibitors on glial inducible nitric-oxide synthase expression. Nitric Oxide 12, 200\u2013209 (2005).","journal-title":"Nitric Oxide"},{"key":"2619_CR24","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0024-3205(01)00967-5","volume":"68","author":"Y Nomura","year":"2001","unstructured":"Nomura, Y. NF-\u03baB activation and I\u03baB\u03b1 dynamism involved in iNOS and chemokine induction in astroglial cells. Life Sci. 68, 1695\u20131701 (2001).","journal-title":"Life Sci."},{"key":"2619_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4","volume":"32","author":"H Possel","year":"2000","unstructured":"Possel, H., Noack, H., Putzke, J., Wolf, G. & Sies, H. Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia 32, 51\u201359 (2000).","journal-title":"Glia"},{"key":"2619_CR26","volume":"5","author":"JW Lee","year":"2008","unstructured":"Lee, J. W. et al. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J. Neuroinflammation 5, 37 (2008).","journal-title":"J. Neuroinflammation"},{"key":"2619_CR27","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-106","volume":"9","author":"D Tweedie","year":"2012","unstructured":"Tweedie, D. et al. Tumor necrosis factor-\u03b1 synthesis inhibitor 3, 6\u2032-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer\u2019s disease. J. Neuroinflammation 9, 106 (2012).","journal-title":"J. Neuroinflammation"},{"key":"2619_CR28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.108.137455","volume":"326","author":"AN Begum","year":"2008","unstructured":"Begum, A. N. et al. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer\u2019s disease. J. Pharmacol. Exp. Therapeutics 326, 196\u2013208 (2008).","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"key":"2619_CR29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.33549\/physiolres.933480","volume":"66","author":"R Zakaria","year":"2017","unstructured":"Zakaria, R. et al. Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer\u2019s disease. Physiological Res. 66, 553\u2013565 (2017).","journal-title":"Physiological Res."},{"key":"2619_CR30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris, R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47\u201360 (1984).","journal-title":"J. Neurosci. Methods"},{"key":"2619_CR31","volume":"15","author":"JY Choi","year":"2018","unstructured":"Choi, J. Y. et al. K284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-kappaB-mediated CHI3L1 expression. J. Neuroinflammation 15, 224 (2018).","journal-title":"J. Neuroinflammation"},{"key":"2619_CR32","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0891-5849(98)00293-7","volume":"26","author":"RA Floyd","year":"1999","unstructured":"Floyd, R. A. Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic. Biol. Med. 26, 1346\u20131355 (1999).","journal-title":"Free Radic. Biol. Med."},{"key":"2619_CR33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1357-4310(99)01453-7","volume":"5","author":"J Licinio","year":"1999","unstructured":"Licinio, J., Prolo, P., McCann, S. M. & Wong, M.-L. Brain iNOS: current understanding and clinical implications. Mol. Med. Today 5, 225\u2013232 (1999).","journal-title":"Mol. Med. Today"},{"key":"2619_CR34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0278-5846(00)00147-0","volume":"25","author":"NR Cutler","year":"2001","unstructured":"Cutler, N. R. & Sramek, J. J. Review of the next generation of Alzheimer\u2019s disease therapeutics: challenges for drug development. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 25, 27\u201357 (2001).","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"2619_CR35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1750-3639.1998.tb00136.x","volume":"8","author":"W Griffin","year":"1998","unstructured":"Griffin, W. et al. Glial\u2010neuronal interactions in Alzheimer\u2019s disease: the potential role of a \u2018cytokine cycle\u2019in disease progression. Brain Pathol. 8, 65\u201372 (1998).","journal-title":"Brain Pathol."},{"key":"2619_CR36","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/ana.410440717","volume":"44","author":"E Hirsch","year":"1998","unstructured":"Hirsch, E., Hunot, S., Damier, P. & Faucheux, B. Glial cells and inflammation in Parkinson\u2019s disease: a role in neurodegeneration? Ann. Neurol. 44, S115\u2013S120 (1998).","journal-title":"Ann. Neurol."},{"key":"2619_CR37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0166-2236(96)01035-1","volume":"20","author":"LA O\u2019Neill","year":"1997","unstructured":"O\u2019Neill, L. A. & Kaltschmidt, C. NF-kB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252\u2013258 (1997).","journal-title":"Trends Neurosci."},{"key":"2619_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0149-7634(00)00048-8","volume":"25","author":"CR Pugh","year":"2001","unstructured":"Pugh, C. R., Fleshner, M., Watkins, L. R., Maier, S. F. & Rudy, J. W. The immune system and memory consolidation: a role for the cytokine IL-1\u03b2. Neurosci. Biobehav. Rev. 25, 29\u201341 (2001).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"2619_CR39","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1523\/JNEUROSCI.3376-06.2006","volume":"26","author":"NL Sparkman","year":"2006","unstructured":"Sparkman, N. L. et al. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J. Neurosci. 26, 10709\u201310716 (2006).","journal-title":"J. Neurosci."},{"key":"2619_CR40","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-23","volume":"9","author":"K Belarbi","year":"2012","unstructured":"Belarbi, K. et al. TNF-\u03b1 protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J. Neuroinflammation 9, 23 (2012).","journal-title":"J. Neuroinflammation"},{"key":"2619_CR41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2014.04.047","volume":"737","author":"T Zheng","year":"2014","unstructured":"Zheng, T., Wang, X. & Yim, M. Miconazole inhibits receptor activator of nuclear factor-kappaB ligand-mediated osteoclast formation and function. Eur. J. Pharmacol. 737, 185\u2013193 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"2619_CR42","doi-asserted-by":"crossref","DOI":"10.1186\/s40893-016-0004-0","volume":"1","author":"P Villoslada","year":"2016","unstructured":"Villoslada, P. Neuroprotective therapies for multiple sclerosis and other demyelinating diseases. Mult. Scler. Demyelinat. Disord. 1, 1 (2016).","journal-title":"Mult. Scler. Demyelinat. Disord."},{"key":"2619_CR43","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1128\/AAC.43.9.2170","volume":"43","author":"L Pitzurra","year":"1999","unstructured":"Pitzurra, L. et al. A new azole derivative of 1,4-benzothiazine increases the antifungal mechanisms of natural effector cells. Antimicrobial Agents Chemother. 43, 2170\u20132175 (1999).","journal-title":"Antimicrobial Agents Chemother."},{"key":"2619_CR44","unstructured":"Silverman, R. B. & Kraus, J. M. Selective neuronal nitric oxide synthase inhibitors with azole substituents. (Google Patents, 2013)."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2619-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:59:01Z","timestamp":1670252341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2619-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["2619"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2619-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"3 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"623"}}